US FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
Healio

FDA asks for removal of suicidal ideation risk from GLP-1 labels following investigation

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...
GlobalData on MSN

Drugmakers welcome FDA’s GLP-1RA suicide warning removal request

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.
MedPage Today on MSN

FDA says to drop suicide warning from GLP-1 drug labels

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Popular weight-loss drugs shouldn't carry suicide warnings, FDA says

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

FDA Wants Suicide Warning Removed From Weight-Loss Drugs

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
Becker's Hospital Review

FDA moves to strike suicide risk warnings from 3 GLP-1s

FDA moves to strike suicide risk warnings from Saxenda, Wegovy, and Zepbound labels after analysis finds no increased risk.
Hosted on MSN

Updates to Food Labeling Rules Explained

The most shocking change in food labeling requirements comes from the FDA's decision to completely ban Red Dye No. 3 from food products, marking a monumental shift in food safety regulations. This ...